Zobuxa 50 mg tablets for cats and dogs
Zobuxa 50 mg tablets for cats and dogs
Not authorised
- Enrofloxacin
Product identification
Medicine name:
Zobuxa 50 mg tablets for cats and dogs
Zobuxa 50 mg comprimidos para gatos e cães
Active substance:
- Enrofloxacin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Portugal
Package description:
- (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet
- (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Europe Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 364/02/11DFVPT
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0197/002
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 17/10/2024